Apprentice has raised money to build out its biopharma-focused augmented reality business.

The 510(k) clearance sets Merck up to make the device available to IVF clinics in the first half of next year.

The project is built upon a device Rani designed to enable the oral delivery of proteins and other molecules that are currently injected.

LivaNova will pay $78 million and commit to almost $150 million more to buy the rest of ImThera and its neurostimulation treatment for sleep apnea.

Success against the primary endpoint in the pivotal trial sets Akili up to file for FDA approval of the digital medicine.

The pact positions Biocartis to register its Idylla RAS tests as companion diagnostics for Amgen's colorectal cancer drug Vectibix. 

Nevro got a CE mark for a new version of its SCS therapy for chronic pain.

Fractyl plans to use the funds to develop its water-filled balloon device, Revita DMR.